I don’t think they would have the infrastructure to go it alone. A distribution licensing deal is the most likely scenario. That way it allows PAA to carry on with other potential revenue opportunities especially the likes of Alzheimer’s and Parkinson’s
Any buy out and the future use of MPL is lost unless some clever new options / dividends are created along the lines of approvals of secondary uses with an end date of say 6 years. That’s probably wishful thinking and extremely unlikely.
Then again most SH would vote to sell at say $3 per share
NZT gone but hasn't forgotten, page-44
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.020(9.09%) |
Mkt cap ! $95.01M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 24.5¢ | 22.0¢ | $254.9K | 1.085M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10127 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 200825 | 6 |
View Market Depth
| Last trade - 16.10pm 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
0.020 ( 9.30 %) |
||||
| Open | High | Low | Volume | ||
| 21.5¢ | 24.5¢ | 21.5¢ | 724342 | ||
| Last updated 15.59pm 11/06/2024 ? | |||||
| PAA (ASX) Chart |